05252018Headline:

Archives

Home

Roopal Luhana

Pennsylvania Woman Blames Onglyza for Heart Failure

On February 2, 2018, a Pennsylvania woman filed a new Onglyza lawsuit in the U.S. District Court for the Western District of Pennsylvania. She filed on behalf of another Pennsylvania woman who took Onglyza to treat her type 2 diabetes […]

Roopal Luhana

North Carolina Woman Claims Kombiglyze XR Caused Congestive Heart Failure

On January 23, 2018, a North Carolina woman filed a new Kombiglyze XR (saxagliptin and metformin) lawsuit against manufacturers Bristol-Myers Squibb and AstraZeneca. She claims that after taking the diabetes medication, she suffered serious injuries that required hospitalization. She filed […]

David Brose

Five Simple Safety Tips for Spring Break Road Trips

My daughter’s spring break begins next week. Thankfully, she’s not old enough to drive, so I don’t have the concern that other parents may feel when their kids head off for spring break road trips. For those who do have […]

Shezad Malik MD JD

Diabetic Patients Angry at J&J over Invokana Amputations

Diabetic Patients Angry at J&J over Invokana Amputations. We have been contacted by many diabetic patients who have expressed anger at Johnson & Johnson the maker of the notorious new type of diabetic medication, Invokana. These folks are frightened and […]

Roopal Luhana

Illinois Man Blames Onglyza for his Heart Failure

On January 9, 2018, an Illinois man filed a new Onglyza lawsuit in the U.S. District Court for the Central District of Illinois.  He claims that after taking the diabetes medication, he suffered serious injuries.  He seeks in excess of […]

James Humann

Complications Associated with Bard’s Recovery IVC Filter May be Introduced in Upcoming Trial Concerning Bard’s G2 IVC Filter

On March 1, 2018, the Court ruled that evidence of the Bard Recovery IVC filter problems may be introduced during the first bellwether trial in multidistrict litigation 2641 (MDL 2641). The Court stated that it would be difficult to try the Booker case without evidence of the Recovery filter and the problems it encountered. Accordingly, Bard’s motion to exclude the evidence was denied and reported problems with the Bard Recovery filter will be fair play in the Booker trial next week.

Eric T. Chaffin

Studies Show Tasigna Increases Risk of Atherosclerosis

Tasigna (nilotinib) is a drug manufactured by Novartis to treat chronic myelogenous leukemia (CML). The FDA approved it for this use in 2007, but since then, there have been several studies that have linked the medication with an increased risk […]

Chuck Paglialunga

Invokana Side Effects – Amputation

An FDA mandated trial has shown that Invokana use doubles the risk of lower limb amputation.  The FDA promptly (July 2017) ordered a black box warning, the most serious warning available.  The drug had already been linked to other dangerous […]

Joseph H. Saunders

DePuy Attune Knee Implant Failures Continue

Patients who have received a DePuy Synthes Attune knee replacement have experienced an unusually high rate of early failure of the tibial component. Many experts say that estimate is far to low since it fails to consider unreported events. A […]

Virgilio Solis

Latest Pennsylvania Superior Court ruling permits Punitive Damages in Philadelphia Risperdal Suits

On January 9, 2018, a three-judge Superior Court panel handed down a decision that could significantly change the landscape of the Philadelphia Risperdal Docket. The three-judge panel ruled that plaintiffs in the Philadelphia cases may apply the law of their […]